Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Juva Life Inc. Updates Shareholders on Financial Status and Upcoming Receivership Hearing
REDWOOD CITY, CA / ACCESSWIRE / November 5, 2024 / Juva Life Inc. (CSE:JUVA)(OTC EXPERT MARKET:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, has been facing a series of challenges that has hindered its ability to both operate as well as meet its financial obligations. This serves as an update to Juva's shareholders regarding recent developments within the Company.» Mehr auf accesswire.com
Juva Life Unveils New Cannabis Vape Category - Rosin Absolute - Introduces Infused Flower Offerings and Announces Partnership With Cloudius9
REDWOOD CITY, CA / ACCESSWIRE / April 16, 2024 / Juva Life Inc. (CSE:JUVA)(OTCQB:JUVAF)(FRANKFURT:4VV) ("Juva Life" or the "Company"), Juva Life Inc, a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, is thrilled to announce the upcoming launch of Rosin Absolute, a new cannabis vape category developed by its flagship brand, Frosted Flowers. Following the initial announcement on October 3, 2023, Frosted Flowers has been diligently working on bringing Rosin Absolute to the California marketplace.» Mehr auf accesswire.com
Juva Life Reports Strong Growth in Q3 2023 Financial Results
REDWOOD CITY, CA / ACCESSWIRE / December 13, 2023 / Juva Life Inc. (CSE:JUVA)(OTCQB:JUVAF)(FRANKFURT:4VV) ("Juva Life" or the "Company"), Juva Life, Inc, a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, is delighted to announce its financial results for the third quarter ending September 30, 2023. Key Highlights: Revenue Growth: Juva Life reported a substantial increase in sales, with Q3 2023 sales reaching $3.17 million, compared to $1.25 million for the same period in 2022.» Mehr auf accesswire.com
Historische Dividenden
Alle DividendenKennzahlenUnternehmenszahlen
(EUR) | Sep. 2023 | |
---|---|---|
Umsatz | 3,00 Mio | - |
Bruttoeinkommen | 1,06 Mio | - |
Nettoeinkommen | −738,56k | - |
EBITDA | 520,89k | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 15,67k€ |
Anzahl Aktien | 164,07 Mio |
52 Wochen-Hoch/Tief | 0,0957€ - 0,0000095€ |
Dividenden | Nein |
Beta | -20,37 |
KGV (PE Ratio) | −0,01 |
KGWV (PEG Ratio) | 0,00 |
KBV (PB Ratio) | 0,00 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
Juva Life Inc. erwirbt, besitzt und betreibt Cannabisgeschäfte in den Bereichen Medizin und Freizeit-Cannabis. Juva Life Inc. wurde im Jahr 2018 gegründet und hat seinen Hauptsitz in Vancouver, Kanada.
Name | Juva Life |
CEO | Douglas Chloupek |
Sitz | Vancouver, bc Schweiz |
Website | |
Industrie | Chemikalien |
Börsengang | 01.05.2015 |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
Pnk | JUVAF |
Cnq | JUVA.CN |
Frankfurt | 4VV.F |
Düsseldorf | 4VV.DU |
München | 4VV.MU |
Assets entdecken
Shareholder von Juva Life investieren auch in folgende Assets